These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

131 related items for PubMed ID: 3105438

  • 1. In vitro susceptibility of gram-positive cocci to paldimycin.
    Pohlod DJ, Saravolatz LD, Somerville MM.
    Antimicrob Agents Chemother; 1987 Jan; 31(1):104-7. PubMed ID: 3105438
    [Abstract] [Full Text] [Related]

  • 2. In vitro evaluation of the new paulomycin antibiotic paldimycin.
    Eliopoulos GM, Reiszner E, Moellering RC.
    Eur J Clin Microbiol; 1987 Jun; 6(3):306-8. PubMed ID: 3622497
    [Abstract] [Full Text] [Related]

  • 3. Susceptibility of staphylococci to paldimycin, and emergence of resistance, in vitro.
    Chandrasekar PH, Sluchak JA.
    J Antimicrob Chemother; 1989 Nov; 24(5):821-4. PubMed ID: 2600003
    [No Abstract] [Full Text] [Related]

  • 4. In-vitro activity of paldimycin against methicillin-resistant and susceptible isolates of Staphylococcus aureus and S. epidermidis.
    Pfaller MA, Bale M, Barrett M.
    J Antimicrob Chemother; 1987 Aug; 20(2):286-8. PubMed ID: 3667485
    [No Abstract] [Full Text] [Related]

  • 5. In vitro activity of paldimycin (U-70138F) against gram-positive bacteria isolated from patients with cancer.
    Rolston KV, LeBlanc B, Ho DH, Bodey GP.
    Antimicrob Agents Chemother; 1987 Apr; 31(4):650-2. PubMed ID: 3606069
    [Abstract] [Full Text] [Related]

  • 6. Comparative in vitro activities of teicoplanin, daptomycin, ramoplanin, vancomycin, and PD127,391 against blood isolates of gram-positive cocci.
    Shonekan D, Mildvan D, Handwerger S.
    Antimicrob Agents Chemother; 1992 Jul; 36(7):1570-2. PubMed ID: 1324649
    [Abstract] [Full Text] [Related]

  • 7. In vitro activity of teichomycin A 2 in comparison with penicillin and vancomycin against gram-positive cocci.
    Bauernfeind A, Petermüller C.
    Eur J Clin Microbiol; 1982 Oct; 1(5):278-81. PubMed ID: 6223812
    [Abstract] [Full Text] [Related]

  • 8. Comparative in-vitro activity of vancomycin, teicoplanin, ramoplanin (formerly A16686), paldimycin, DuP 721 and DuP 105 against methicillin and gentamicin resistant Staphylococcus aureus.
    Maple PA, Hamilton-Miller JM, Brumfitt W.
    J Antimicrob Chemother; 1989 Apr; 23(4):517-25. PubMed ID: 2526111
    [Abstract] [Full Text] [Related]

  • 9. Effect of human serum on the bactericidal activity of daptomycin and vancomycin against staphylococcal and enterococcal isolates as determined by time-kill kinetic studies.
    Stratton CW, Weeks LS.
    Diagn Microbiol Infect Dis; 1990 Apr; 13(3):245-52. PubMed ID: 2166634
    [Abstract] [Full Text] [Related]

  • 10. In vitro activities of daptomycin (LY146032) and paldimycin (U-70,138F) against anaerobic gram-positive bacteria.
    Chow AW, Cheng N.
    Antimicrob Agents Chemother; 1988 May; 32(5):788-90. PubMed ID: 2840019
    [Abstract] [Full Text] [Related]

  • 11. In vitro activity of the new glycopeptide decaplanin.
    Neu HC, Chin NX, Niu WW.
    Eur J Clin Microbiol Infect Dis; 1992 May; 11(5):458-62. PubMed ID: 1330562
    [Abstract] [Full Text] [Related]

  • 12. Quality control limits for teicoplanin susceptibility tests and confirmation of disk diffusion interpretive criteria.
    Barry AL, Jones RN, Gavan TL, Thornsberry C.
    J Clin Microbiol; 1987 Sep; 25(9):1812-4. PubMed ID: 2958498
    [Abstract] [Full Text] [Related]

  • 13. In-vitro comparison of the post-antibiotic effect of vancomycin and teicoplanin.
    Cooper MA, Jin YF, Ashby JP, Andrews JM, Wise R.
    J Antimicrob Chemother; 1990 Aug; 26(2):203-7. PubMed ID: 2145256
    [Abstract] [Full Text] [Related]

  • 14. In vitro activity of teicoplanin against gram-positive cocci.
    Allouch P, Pina P, Chaplain C, Delarbre JM, Geffroy F, Grasmick CP, Marcolin M, Morel A, Pangon B, Rio Y, Sédaillan A.
    Pathol Biol (Paris); 2000 Oct; 48(8):792-5. PubMed ID: 11244609
    [Abstract] [Full Text] [Related]

  • 15. [The invitro activity of teicoplanin and vancomycin against gram positive microorganisms (corrected)].
    Kayaokay Y, Hasçelik G, Gür D, Akalin E.
    Mikrobiyol Bul; 1991 Oct; 25(4):321-5. PubMed ID: 1839050
    [Abstract] [Full Text] [Related]

  • 16. Comparative in vitro activity of LY146032 (daptomycin) against gram-positive cocci.
    Machka K, Braveny I.
    Eur J Clin Microbiol; 1987 Feb; 6(1):96-9. PubMed ID: 3032613
    [Abstract] [Full Text] [Related]

  • 17. In-vitro susceptibility of gram-positive cocci to LY146032 teicoplanin, sodium fusidate, vancomycin, and rifampicin.
    Pohlod DJ, Saravolatz LD, Somerville MM.
    J Antimicrob Chemother; 1987 Aug; 20(2):197-202. PubMed ID: 2822646
    [Abstract] [Full Text] [Related]

  • 18. In vitro activities of quinupristin/dalfopristin and eight other antimicrobial agents against 360 clinical isolates from Korea.
    Hwang SH, Kim MN, Pai CH, Huh DH, Shin WS.
    Yonsei Med J; 2000 Oct; 41(5):563-9. PubMed ID: 11079615
    [Abstract] [Full Text] [Related]

  • 19. [In vitro activity of vancomycin and teicoplanin against gram-positive cocci].
    Bezian MC, Ribou G, Masquelier B.
    Pathol Biol (Paris); 1992 May; 40(5):461-5. PubMed ID: 1386667
    [Abstract] [Full Text] [Related]

  • 20. Augmentation of serum bactericidal activity by paldimycin.
    Cialdella JI, Ulrich RG, Marshall VP.
    J Antibiot (Tokyo); 1988 May; 41(5):660-6. PubMed ID: 3384752
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.